$90.86
0.650.72%
Últ. Act.: Aug 31, 11:26 AM
Edwards Lifesciences Corp
EWNYSE
Edwards Lifesciences Earnings & Forecasts
Edwards Lifesciences (EW) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Edwards Lifesciences Guidance
Edwards Lifesciences (EW) emitió su última guía sobre julio 23, 2026 para Q3 2026. La compañía estimó unas ganancias por acción en el rango de $0.71 - $0.77, en comparación con una estimación de consenso de EPS de $0.74. Edwards Lifesciences también estimó unos ingresos en el rango de $1.63B - $1.71B para el período.
En comparación con la previsión anterior, Edwards Lifesciences reducido redujo su previsión de ingresos desde un rango anterior de $6.6B - $6.9B.
Edwards Lifesciences ha emitido 40 actualizaciones de orientación entre el octubre 27, 2022 y el julio 23, 2026. During this period, the company raised its outlook 6 times and lowered it 17 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.74 | $0.73 | $0.62 | $0.59 |
| Actual | $0.78 | $0.78 | $0.58 | $0.67 |
| Surprise | +5.41% | +6.85% | -6.45% | +13.6% |
| Revenue | ||||
| Estimate | $1.70B | $1.59B | $1.54B | $1.50B |
| Actual | $1.74B | $1.65B | $1.57B | $1.55B |
| Surprise | +2.42% | +3.41% | +1.81% | +3.66% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.74 | $0.71 | $0.84 | $0.86 |
| Revenue | ||||
| Consensus | $1.68B | $1.70B | — | — |